Advertisement
Screener

CRONOS GROUP INC. (CRON) EBITDA

CRONOS GROUP INC. (CRON) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $10.78M*; Operating income $7.40M; Depreciation and amortization $3.37M*.
  • 2026-03-31: Basis Reported; EBITDA $1.89M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$3.84M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $3.03M*; Operating income -$503.00K; Depreciation and amortization $3.53M*.

Complete source-backed ebitda history.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$10.78M*$7.40M$3.37M*$53.01M20.33%*$1.74M*$24.01M*(m)$1.22M(m)$51.00K
2026-03-31Reported$1.89M(m)(m)(m)4.19%$1.88M$10.90M(m)$1.41M(m)$2.43M
2025-12-31Reported-$3.84M(m)(m)(m)-8.62%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$3.03M*-$503.00K$3.53M*$36.34M8.34%*$4.48M*$13.31M*(m)$1.34M(m)-$1.32M
2025-06-30Reported-$1.12M*-$5.32M$4.20M*$33.45M-3.35%*$3.84M*$2.82M*(m)$929.00K(m)-$525.00K
2025-03-31Reported-$1.23M(m)(m)(m)-3.82%$15.26M-$2.10M(m)$793.00K(m)-$455.00K
2024-12-31Reported-$8.84M(m)(m)(m)-29.17%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$30.09M*-$33.66M$3.57M*$34.26M-87.81%*$6.42M*$11.58M*(m)$1.24M(m)-$2.71M
2024-06-30Reported-$14.05M*-$15.56M$1.51M*$27.76M-50.60%*$729.00K*$1.74M*(m)$962.00K(m)-$2.17M
2024-03-31Reported-$14.22M(m)(m)(m)-56.22%$1.72M-$2.20M(m)$997.00K(m)-$558.00K
2023-12-31Reported-$20.46M(m)(m)(m)-85.55%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$19.63M*-$21.77M$2.15M*$24.81M-79.11%*-$11.00K*-$183.00K*(m)$1.25M(m)-$1.25M
2023-06-30Reported-$18.24M*-$20.62M$2.38M*$19.02M-95.89%*$494.00K*-$11.77M*(m)$1.11M(m)-$180.00K
2023-03-31Reported-$18.36M(m)(m)(m)-94.20%$804.00K-$47.69M(m)$2.04M(m)-$1.44M
2022-12-31Reported-$24.41M(m)(m)(m)-110.78%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$23.89M(m)(m)(m)-117.04%$869.00K*-$13.38M*(m)$2.54M(m)$2.12M
2022-06-30Reported-$21.08M(m)(m)(m)-97.56%$1.51M*-$17.28M*(m)$4.19M(m)-$308.00K
2022-03-31Reported-$33.23M(m)(m)(m)-132.72%$711.00K-$33.91M(m)$4.04M(m)$362.00K
2021-12-31Reported$112.48M(m)(m)(m)706.49%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$52.59M(m)(m)(m)-257.69%$2.30M*-$31.48M*(m)$6.47M(m)-$159.00K
2021-06-30Reported-$293.14M(m)(m)(m)-1876.47%$1.67M*-$39.58M*(m)$5.20M(m)$0.00
2021-03-31Reported-$43.32M(m)(m)(m)-343.51%$6.68M-$46.62M(m)$5.10M(m)$0.00
2020-12-31Reported-$56.5M(m)(m)(m)-331.46%(m)(m)(m)(m)(m)(m)
2020-09-30Reported-$38.95M(m)(m)(m)-342.96%$7.99M*-$28.17M*(m)$4.73M(m)$988.00K
2020-06-30Reported-$32.99M(m)(m)(m)-333.82%$6.93M*-$39.48M*(m)$3.63M(m)$0.00
2020-03-31Reported-$43.9M(m)(m)(m)-520.61%$6.41M-$38.90M(m)$4.59M(m)$0.00
2019-12-31Reported-$94.46M(m)(m)(m)-1292.58%(m)(m)(m)(m)(m)(m)
2019-09-30Reported-$28.92M*-$30.70M$1.78M*$5.79M-499.84%*$16.70M*-$20.02M*(m)$2.60M(m)$58.00K
2019-06-30Reported-$16.07M*-$16.75M$680.00K*$7.65M-210.05%*$10.80M*-$42.93M*(m)$2.30M(m)$0.00
2019-03-31Reported-$9.63M(m)(m)(m)-320.64%$10.12M-$13.84M(m)$1.17M(m)$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$3.16M(m)(m)(m)-2.16%$25.72M$25.87M(m)$4.45M(m)-$14.19M
2024-12-31Reported-$67.19M(m)(m)(m)-57.13%$12.41M$18.84M(m)$4.23M(m)-$3.44M
2023-12-31Reported-$76.69M(m)(m)(m)-87.91%$2.50M-$42.84M(m)$5.84M(m)-$3.23M
2022-12-31Reported-$98.31M(m)(m)(m)-113.32%$3.45M-$88.95M(m)$13.13M(m)$34.17M
2021-12-31Reported-$276.57M(m)(m)(m)-428.38%$11.14M-$153.62M(m)$21.84M(m)-$431.00K
2020-12-31Reported-$212.34M(m)(m)(m)-454.51%$31.41M-$144.87M(m)$20.37M(m)$1.35M
2019-12-31Reported-$149.05M(m)(m)(m)-627.56%$38.66M-$131.19M(m)$12.15M(m)$0.00
2018-12-31Reported-$18.51M(m)(m)(m)-152.69%$88.31M-$7.52M(m)$1.81M(m)$0.00
2017-12-31Reported-$5.35M*-$6.12M$768.00K$3.15M-170.10%*$32.93M-$4.28M(m)$0.00(m)-$862.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87